Cardinal Health stock gains 1.59% ahead of Q1 earnings test

Cardinal Health stock gained 1.59 percent from the quote in our previous report as the company approaches its fiscal 2027 first-quarter results. The latest market preview from MarketBeat sets quarterly expectations at 2.94 US dollars in adjusted earnings per share and 66.67 billion US dollars in revenue.

Cardinal Health stock traded at 226.90 euros on Lang & Schwarz at 3:40 p.m. CEST on Friday, October 30, 2026. That was 1.59 percent above the 223.35-euro quote in the previous report published on Thursday, October 29, at 4:38 p.m. Berlin time.

Results are the next catalyst

Cardinal Health plans to publish fiscal 2027 first-quarter results before the New York market opens on Thursday, November 5. The company has scheduled an investor webcast for 8:30 a.m. Eastern time.

For the full fiscal year, Cardinal Health maintains non-GAAP earnings guidance of 12.40 to 12.60 US dollars per share. The range reflects adjusted fiscal 2026 results that exclude the fiscal 2026 IEEPA tariff refund benefit.

Estimates frame the earnings test

MarketBeat said the previous quarter produced adjusted earnings of 2.91 US dollars per share against a 2.42-dollar consensus estimate. Revenue reached 63.67 billion US dollars, up 5.8 percent from the year-earlier period, but came in below the cited 65.15-billion-dollar estimate.

The upcoming release will show whether quarterly results support the existing full-year outlook. MarketBeat also reported insider sales of 210,271 shares worth 49.63 million US dollars over the past 90 days, a factor investors may weigh alongside the earnings figures.

Cardinal Health stock has a real-time quote of Cardinal Health stock.

For the broader market backdrop, investors can follow the S&P 500 market theme.

More news and analyses on Cardinal Health stock remain available ahead of the results.